A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Inventiva Pharma
Sven M Francque; Pierre Bedossa; Vlad Ratziu; Quentin M Anstee; Elisabetta Bugianesi; Arun J Sanyal; Rohit Loomba; Stephen A Harrison; Rozalina Balabanska; Lyudmila Mateva; Nicolas Lanthier; Naim Alkhouri; Christophe Moreno; Jörn M Schattenberg; Diana Stefanova-Petrova; Luisa Vonghia; Régine Rouzier; Maeva Guillaume; Alexander Hodge; Manuel Romero-Gómez; Philippe Huot-Marchand; Martine Baudin; Marie-Paule Richard; Jean-Louis Abitbol; Pierre Broqua; Jean-Louis Junien; Manal F Abdelmalek; NATIVE Study Group